96 related articles for article (PubMed ID: 24918618)
1. Low-serum testosterone levels pre-liver transplantation are associated with reduced rates of early acute allograft rejection in men.
Sinclair M; Angus PW; Gow PJ; Hoermann R; Mogilevski T; Grossmann M
Transplantation; 2014 Oct; 98(7):788-92. PubMed ID: 24918618
[TBL] [Abstract][Full Text] [Related]
2. Low serum testosterone is associated with adverse outcome in men with cirrhosis independent of the model for end-stage liver disease score.
Sinclair M; Gow PJ; Grossmann M; Shannon A; Hoermann R; Angus PW
Liver Transpl; 2016 Nov; 22(11):1482-1490. PubMed ID: 27542090
[TBL] [Abstract][Full Text] [Related]
3. Significance of central perivenulitis in pediatric liver transplantation.
Abraham SC; Freese DK; Ishitani MB; Krasinskas AM; Wu TT
Am J Surg Pathol; 2008 Oct; 32(10):1479-88. PubMed ID: 18708942
[TBL] [Abstract][Full Text] [Related]
4. Impact of immunosuppression and acute rejection on recurrence of hepatitis C: results of the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database.
Charlton M; Seaberg E
Liver Transpl Surg; 1999 Jul; 5(4 Suppl 1):S107-14. PubMed ID: 10431024
[TBL] [Abstract][Full Text] [Related]
5. Relation between pretransplant serum levels of soluble CD30 and acute rejection during the first 6 months after a kidney transplant.
Shooshtarizadeh T; Mohammadali A; Ossareh S; Ataipour Y
Exp Clin Transplant; 2013 Jun; 11(3):229-33. PubMed ID: 23477385
[TBL] [Abstract][Full Text] [Related]
6. Low testosterone at time of transplantation is independently associated with poor patient and graft survival in male renal transplant recipients.
Shoskes DA; Kerr H; Askar M; Goldfarb DA; Schold J
J Urol; 2014 Oct; 192(4):1168-71. PubMed ID: 24704018
[TBL] [Abstract][Full Text] [Related]
7. High serum soluble CD30 does not predict acute rejection in liver transplant patients.
Matinlauri I; Höckerstedt K; Isoniemi H
Transplant Proc; 2006 Dec; 38(10):3601-4. PubMed ID: 17175343
[TBL] [Abstract][Full Text] [Related]
8. CD44 and CXCL9 serum protein levels predict the risk of clinically significant allograft rejection after liver transplantation.
Raschzok N; Reutzel-Selke A; Schmuck RB; Morgul MH; Gauger U; Prabowo KA; Tannus LM; Leder A; Struecker B; Boas-Knoop S; Bartels M; Jonas S; Lojewski C; Puhl G; Seehofer D; Bahra M; Pascher A; Pratschke J; Sauer IM
Liver Transpl; 2015 Sep; 21(9):1195-207. PubMed ID: 25950774
[TBL] [Abstract][Full Text] [Related]
9. Chronic hepatitis C infection and sex hormone levels: effect of disease severity and recombinant interferon-alpha therapy.
Nguyen HV; Mollison LC; Taylor TW; Chubb SA; Yeap BB
Intern Med J; 2006 Jun; 36(6):362-6. PubMed ID: 16732861
[TBL] [Abstract][Full Text] [Related]
10. Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation.
Rosen HR; Shackleton CR; Higa L; Gralnek IM; Farmer DA; McDiarmid SV; Holt C; Lewin KJ; Busuttil RW; Martin P
Am J Gastroenterol; 1997 Sep; 92(9):1453-7. PubMed ID: 9317061
[TBL] [Abstract][Full Text] [Related]
11. The risk factors to predict acute rejection in liver transplantation.
Wang YC; Wu TJ; Wu TH; Lee CF; Chou HS; Chan KM; Lee WC
Transplant Proc; 2012 Mar; 44(2):526-8. PubMed ID: 22410062
[TBL] [Abstract][Full Text] [Related]
12. Toll-like receptor 3 L412F polymorphism may protect against acute graft rejection in adult patients undergoing liver transplantation for hepatitis C-related cirrhosis.
Citores MJ; Baños I; Noblejas A; Rosado S; Castejon R; Cuervas-Mons V
Transplant Proc; 2011; 43(6):2224-6. PubMed ID: 21839239
[TBL] [Abstract][Full Text] [Related]
13. Immune function assay (ImmuKnow) as a predictor of allograft rejection and infection in kidney transplantation.
He J; Li Y; Zhang H; Wei X; Zheng H; Xu C; Bao X; Yuan X; Hou J
Clin Transplant; 2013; 27(4):E351-8. PubMed ID: 23682828
[TBL] [Abstract][Full Text] [Related]
14. Impact of preoperative serum sodium concentration in living donor liver transplantation.
Fukuhara T; Ikegami T; Morita K; Umeda K; Ueda S; Nagata S; Sugimachi K; Gion T; Yoshizumi T; Soejima Y; Taketomi A; Maehara Y
J Gastroenterol Hepatol; 2010 May; 25(5):978-84. PubMed ID: 20546453
[TBL] [Abstract][Full Text] [Related]
15. The absence of chronic rejection in pediatric primary liver transplant patients who are maintained on tacrolimus-based immunosuppression: a long-term analysis.
Jain A; Mazariegos G; Pokharna R; Parizhskaya M; Kashyap R; Kosmach-Park B; Smith A; Fung JJ; Reyes J
Transplantation; 2003 Apr; 75(7):1020-5. PubMed ID: 12698091
[TBL] [Abstract][Full Text] [Related]
16. Incidence of rejection and infection after liver transplantation as a function of the primary disease: possible influence of alcohol and polyclonal immunoglobulins.
Farges O; Saliba F; Farhamant H; Samuel D; Bismuth A; Reynes M; Bismuth H
Hepatology; 1996 Feb; 23(2):240-8. PubMed ID: 8591847
[TBL] [Abstract][Full Text] [Related]
17. Pretransplantation tumor necrosis factor-alpha production predicts acute rejection after liver transplantation.
Bathgate AJ; Lee P; Hayes PC; Simpson KJ
Liver Transpl; 2000 Nov; 6(6):721-7. PubMed ID: 11084058
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D and the risk of acute allograft rejection following human liver transplantation.
Bitetto D; Fabris C; Falleti E; Fornasiere E; Fumolo E; Fontanini E; Cussigh A; Occhino G; Baccarani U; Pirisi M; Toniutto P
Liver Int; 2010 Mar; 30(3):417-44. PubMed ID: 19849776
[TBL] [Abstract][Full Text] [Related]
19. Hypomagnesemia and the risk of new-onset diabetes after liver transplantation.
Van Laecke S; Desideri F; Geerts A; Van Vlierberghe H; Berrevoet F; Rogiers X; Troisi R; de Hemptinne B; Vanholder R; Colle I
Liver Transpl; 2010 Nov; 16(11):1278-87. PubMed ID: 21031543
[TBL] [Abstract][Full Text] [Related]
20. Early tacrolimus exposure after liver transplantation: relationship with moderate/severe acute rejection and long-term outcome.
Rodríguez-Perálvarez M; Germani G; Papastergiou V; Tsochatzis E; Thalassinos E; Luong TV; Rolando N; Dhillon AP; Patch D; O'Beirne J; Thorburn D; Burroughs AK
J Hepatol; 2013 Feb; 58(2):262-70. PubMed ID: 23023010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
